NVIDIA
corporateWebsite
sub field
AI / ML
resource type
Compute / GPU
Fund rating
0.0 / 35
0 published reviews
No per-dimension scores yet.
Published reviews
About
NVIDIA made a $50 million investment in Recursion to advance AI-enabled drug discovery, indicating strategic financing appetite for computational drug-discovery platforms relevant to a single-cell drug atlas.